India, March 4 -- Zydus Lifesciences Limited, a global innovation-driven life sciences company, has announced its groundbreaking initiative to develop the world's first combination vaccine against Typhoid and Shigellosis. This pioneering effort highlights India's innovation prowess and has the potential to protect millions from two deadly enteric diseases.
Set to begin in March 2025, the project will involve early-stage development, animal immunogenicity studies, and regulatory preclinical toxicology studies. Supported by the Gates Foundation, Zydus will collaborate with a partner to co-develop the vaccine by integrating its WHO-prequalified Typhoid conjugate vaccine (ZyVac™ TCV) with a Shigella vaccine from its partner.
Vaccination...